ARTV
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ: ARTV · HEALTHCARE · BIOTECHNOLOGY
$10.24
+17.43% today
Updated 2026-04-30
Market cap
$255.08M
P/E ratio
—
P/S ratio
8.11x
EPS (TTM)
$-3.43
Dividend yield
—
52W range
$1 – $15
Volume
0.3M
Artiva Biotherapeutics, Inc. Common Stock (ARTV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-56.60%
ROA
-33.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-17.99M | — | — | — |
| 2021 | $2.00M | $-71.83M | 100.00% | -2,660.94% | -3,587.66% |
| 2022 | $4.93M | $-58.39M | 100.00% | -1,213.32% | -1,184.10% |
| 2023 | $33.49M | $-27.70M | 100.00% | -91.58% | -82.69% |
| 2024 | $251000.00 | $-58.49M | 100.00% | -26,805.58% | -23,303.98% |
| 2025 | $0.00 | $-83.86M | — | — | — |